Literature DB >> 6366180

Surgically correctable fetal hydrops.

E S Golladay, D L Mollitt.   

Abstract

Hydrops fetalis is classically the result of immune mediated intrauterine hemolysis. Increasingly, however, nonimmunologic abnormalities have been associated with fetal anasarca. A number of these are potentially surgically correctable. Four such infants have been treated at the Arkansas Children's Hospital since 1981. Fetal hydrops was detected prenatally in three, as well as lesions which might be corrected. All three were delivered by cesarean section with vigorous resuscitation required. Following stabilization, each underwent operation with excision of an intrathoracic mass (teratoma and leiomyosarcoma) in two and closure of omphalocele in the remaining neonate. A fourth infant was transferred following spontaneous premature vaginal delivery with hydrops and respiratory distress. This was associated with adenomatoid malformation which was subsequently excised. Anasarca and respiratory distress resolved postoperatively in all. With evidence of nonimmune hydrops, a thorough evaluation for surgically correctable lesions is indicated. A planned aggressive approach to delivery, resuscitation and stabilization followed by prompt surgical intervention can improve the morbidity associated with nonimmune hydrops fetalis having surgically correctable malformations.

Entities:  

Mesh:

Year:  1984        PMID: 6366180     DOI: 10.1016/s0022-3468(84)80017-2

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  3 in total

1.  Antenatal diagnosis of pulmonary tumours: report of two cases.

Authors:  E F Avni; A Vanderelst; D Van Gansbeke; J Schils; F Rodesch
Journal:  Pediatr Radiol       Date:  1986

Review 2.  Management of the fetus with a cystic adenomatoid malformation.

Authors:  N S Adzick; M R Harrison
Journal:  World J Surg       Date:  1993 May-Jun       Impact factor: 3.352

3.  The fetus as a patient. Surgical considerations.

Authors:  M R Harrison; N S Adzick
Journal:  Ann Surg       Date:  1991-04       Impact factor: 12.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.